Satsuma Pharmaceuticals Price on June 6, 2023

STSADelisted Stock  USD 1.10  0.01  0.90%   
If you're considering investing in Satsuma Stock, it is important to understand the factors that can impact its price. As of today, the current price of Satsuma Pharmaceuticals stands at 1.10, as last reported on the 23rd of November, with the highest price reaching 1.14 and the lowest price hitting 1.01 during the day. We have found thirty technical indicators for Satsuma Pharmaceuticals, which you can use to evaluate the volatility of the company. Please validate Satsuma Pharmaceuticals' Coefficient Of Variation of 1667.7, risk adjusted performance of 0.0551, and Semi Deviation of 3.54 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Satsuma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
STSA
Based on monthly moving average Satsuma Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Satsuma Pharmaceuticals by adding Satsuma Pharmaceuticals to a well-diversified portfolio.

Related Headline

PepGen Headline on 6th of June 2023

Filed transaction by Pepgen Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Satsuma Pharmaceuticals Valuation on June 6, 2023

It is possible to determine the worth of Satsuma Pharmaceuticals on a given historical date. On June 6, 2023 Satsuma was worth 1.05 at the beginning of the trading date compared to the closed value of 1.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Satsuma Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Satsuma Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Satsuma Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Satsuma Pharmaceuticals' related companies.
 Open High Low Close Volume
  1.03    1.07    1.03    1.07    259,219  
06/06/2023
  1.05    1.14    1.05    1.11    335,461  
  1.11    1.14    1.01    1.10    1,829,701  
Backtest Satsuma Pharmaceuticals  |  Satsuma Pharmaceuticals History  |  Satsuma Pharmaceuticals Valuation   PreviousNext  
Open Value
1.05
1.11
Closing Value
1.05
Upside

Satsuma Pharmaceuticals Trading Date Momentum on June 6, 2023

On June 07 2023 Satsuma Pharmaceuticals was traded for  1.10  at the closing time. The top price for the day was 1.14  and the lowest listed price was  1.01 . The trading volume for the day was 1.8 M. The trading history from June 7, 2023 was a factor to the next trading day price decrease. The trading price change against the next closing price was 0.90% . The trading price change against the current closing price is 0.00% .

Satsuma Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Satsuma Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Satsuma Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Satsuma financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Satsuma Pharmaceuticals Stock history

Satsuma Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Satsuma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Satsuma Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Satsuma Pharmaceuticals stock prices may prove useful in developing a viable investing in Satsuma Pharmaceuticals
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. Satsuma Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 25 people.

Satsuma Pharmaceuticals Stock Technical Analysis

Satsuma Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Satsuma Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Satsuma Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Satsuma Pharmaceuticals Period Price Range

Low
November 23, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Satsuma Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Satsuma Pharmaceuticals November 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Satsuma Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Satsuma Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Satsuma Pharmaceuticals stock market strength indicators, traders can identify Satsuma Pharmaceuticals entry and exit signals to maximize returns

Satsuma Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Satsuma Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Satsuma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Satsuma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Satsuma Stock

If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years